Skip to Content

Valturna Approval History

  • FDA approved: Yes (First approved September 16th, 2009)
  • Brand name: Valturna
  • Generic name: aliskiren and valsartan
  • Dosage form: Tablets
  • Company: Novartis
  • Treatment for: High Blood Pressure

Valturna is a combination of aliskiren (a direct renin inhibitor) and valsartan (an angiotensin II receptor blocker) indicated for the treatment of high blood pressure.

Development History and FDA Approval Process for Valturna

DateArticle
Sep 17, 2009Approval Novartis receives FDA approval for Valturna, a single-pill combination of valsartan and aliskiren, to treat high blood pressure

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide